BlackRock
AEON icon

BlackRock’s AEON Biopharma AEON Stock Holding History

BlackRock’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.79K Hold
2,834
– – ﹤0.01% 5499
2025
Q4 		$3.12K Hold
2,834
– – ﹤0.01% 5372
2025
Q3 		$2.29K Sell
2,834
-21
-0.7% -$16 ﹤0.01% 5316
2025
Q2 		$2.17K Sell
2,855
-816
-22% -$468 ﹤0.01% 5317
2025
Q1 		$2.13K Sell
3,671
-17
-0.5% -$121 ﹤0.01% 5297
2024
Q4 		$143K Buy
3,688
+5
+0.1% +$291 ﹤0.01% 4691
2024
Q3 		$278K Sell
3,683
-99
-3% -$8.71K ﹤0.01% 4459
2024
Q2 		$286K Buy
3,782
+234
+7% +$55.8K ﹤0.01% 4475
2024
Q1 		$2.96M Buy
3,548
+116
+3% +$84K ﹤0.01% 3864
2023
Q4 		$1.78M Buy
3,432
+77
+2% +$30.9K ﹤0.01% 4082
2023
Q3 		$1.35M Buy
+3,355
New +$1.54M ﹤0.01% 4144
2023
Q1 		– Sell
-139
Closed -$101K – 5566
2022
Q4 		$101K Hold
139
– – ﹤0.01% 5040
2022
Q3 		$99K Buy
+139
New +$98.4K ﹤0.01% 5176

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock's AEON Position: Q1 2026 in Review

BlackRock held its AEON Biopharma (AEON) position steady in Q1 2026 at 2,834 shares worth $2.79K. The position accounts for ﹤0.01% of the portfolio, ranked #5499.

BlackRock first reported a position in AEON in Q3 2022 and has held it in 13 quarters since. The position peaked at $2.96M in Q1 2024. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • BlackRock held 2,834 shares of AEON Biopharma worth $2.79K as of Q1 2026.
  • BlackRock left its AEON Biopharma share count unchanged in Q1 2026.
  • AEON Biopharma made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5499 holding.
  • BlackRock first reported a position in AEON Biopharma in Q3 2022 and has held it in 13 quarters since.
  • BlackRock's AEON Biopharma position peaked at $2.96M in Q1 2024.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.